Fluorimetric determination of aminocaproic acid in pharmaceutical formulations using a sequential injection analysis system

A sequential injection analysis (SIA) methodology for the fluorimetric determination of aminocaproic acid in pharmaceutical formulations is proposed. The developed analytical procedure is based on the derivatisation reaction of the aminocaproic primary amine with o-phthalaldehyde (OPA) and N-acetylcysteine (NAC) and fluorimetric detection of the formed product (λ_ex = 350 nm; λ_em = 450 nm). The implementation of a SIA flow system allowed for the development of a simple, fast and versatile automated methodology, which exhibits evident advantages regarding the US Pharmacopoeia 24 (USP 24) reference procedure. By combining the SIA time-based sample insertion with a subsequent zone sampling approach, which permitted to select for detection of a well-defined sample zone, it was possible to implement an on-line dilution strategy that enabled the expansion of the analytical working range of the methodology, and thus its application in dissolution studies, without manifold re-configuration.Linear calibration plots were obtained for aminocaproic acid concentrations up to 6 × 10⁻⁵ mol l⁻¹. The developed methodology exhibit a good precision, with a R.S.D. < 2.0% (n = 15) and the detection limit was 2.5 × 10⁻⁷ mol l⁻¹. The obtained results complied with those furnished by the reference procedure with a relative deviation lower than 1.2%. No interference was found.     

A reagent-free method based on a photo-induced fluorimetry in a sequential injection system

According to the current demands of environmentally friendly analytical chemistry and with a view to achieving lower reagent consumption with improved analytical performance, an automatic methodology composed of a photoreactor and fluorimetric detection (λ_exc = 287 nm, λ_em = 378 nm) was developed. To this end, a sequential injection analysis (SIA) system was developed for indomethacin determination using ultra-violet (UV) light which promotes an increase in the fluorescence of indomethacin. This increase in sensitivity makes it possible to apply this methodology to a dissolution test and to determine indomethacin in pharmaceutical formulations.The calibration graph for indomethacin was linear between 4.10 × 10⁻⁶ and 9.00 × 10⁻⁵ mol L⁻¹and the detection limit was 1.23 × 10⁻⁶ mol L⁻¹. The method was proven to be reproducible with a R.S.D. < 5% and sampling rate of approximately 20 per hour. The potential effect of several compounds commonly used as excipients on analytical signals was studied and no interfering effect was observed. Statistical evaluation at the 95% confidence level showed good agreement between the results obtained for the pharmaceutical samples with both the SIA system and comparison batch procedures.     

Rapid spectrophotometric determination of fosfestrol following on-line hydrolysis by alkaline phosphatase using flow injection and chasing zones

A new flow injection (FI) method is reported for the spectrophotometric determination of fosfestrol (diethyl-stilbestrol (DES) diphosphate) in pharmaceutical formulations. The proposed method is based on the on-line hydrolysis of the analyte by alkaline phosphatase (Al-Pase) using a “chasing zones” FI manifold. The orthophosphate ions, thus, generated are determined spectrophotometrically (λ_max=690 nm) using the molybdenum blue approach. The chemical and FI variables affecting the enzymatic reaction were investigated. The proposed method is very precise (s_r=1.1% at 1×10⁻⁴ mol l⁻¹ fosfestrol, n=12), fast (allowing up to 40 samples h⁻¹ to be analyzed) and has a determination range of 2×10⁻⁵ to 2×10⁻⁴ mol l⁻¹, with a satisfactory 3σ detection limit of 5×10⁻⁶ mol l⁻¹. The method was shown to provide accurate determinations of the fosfestrol concentration in a pharmaceutical formulation, giving relative errors, e_r, of +0.6 and −0.5% compared to the value stated by the supplier (Asta Medica Inc.) and the concentration derived using a method recommended by the United States Pharmacopoeia XXI, respectively. In addition, the average recoveries of known amounts of the analyte ranged between 99.2 and 101.2%.     

Sequential injection fluorimetric determination of Sn in juices of canned fruits

The present work describes the development of a fast and robust sequential injection fluorimetric procedure for the determination of Sn in juices of canned fruits. The developed automatic methodology is based on the complexation of Sn with 8-hydroxyquinoline-5-sulfonic acid (HQSA) to form a fluorimetric product (λ_exc = 354 nm; λ_em = 510 nm). The influence of dimethylsulfoxide (DMSO) and cetylpyridinium bromide (CPB) on the sensitivity of the fluorimetric determination was evaluated.Linear calibration plots were obtained for Sn concentrations between 1 and 10 mg L⁻¹, with a detection limit of 0.38 mg L⁻¹. In each analytical cycle 0.006 mg of HQSA and 0.47 mg of CPB were consumed and 1.5 mL of effluent was generated.The developed methodology was applied to the determination of Sn in juices of canned fruits and the results complied with those furnished by an electrothermal atomic absorption spectrometry comparison procedure, with relative deviations lower than 5.2%.The automatic procedure exhibited good precision (R.S.D. < 1.4%) and the sampling rate was about 70 determinations per hour.     

Normal spectrophotometric and stopped-flow spectrofluorimetric sequential injection methods for the determination of alendronic acid, an anti-osteoporosis amino-bisphosphonate drug, in pharmaceuticals

A normal spectrophotometric and a stopped-flow (SF) spectrofluorimetric method have been developed and optimized for the determination of alendronic acid (ALD) in its pharmaceutical formulations. Both methods are automated using the sequential injection analysis (SIA) principle. The spectrophotometric assay is based on the reaction of the analyte with Cu(II) ions in acidic medium to form an UV-absorbing derivative (λ_max = 240 nm). The SF spectrofluorimetric method is based on the reaction of ALD with o-phthalaldehyde (OPA) in the presence of 2-mercaptoethanol at basic medium (λ_ex = 340 nm/λ_em = 455 nm). Linear calibration curves were obtained in the range 1.0-60.0 mg l⁻¹ ALD for the UV method, and in the range 0.13-10.0 mg l⁻¹ ALD for the SF spectrofluorimetric one. The sampling rates were 60 and 30 h⁻¹, respectively. The developed assays are critically compared and their advantages are discussed. Both methods were applied to the analysis of an ALD containing pharmaceutical formulation with satisfactory accuracy and precision.     

A novel application of immobilization on membranes for the separation and spectrofluorimetric quantification of amiloride and furosemide in pharmaceutical samples

A new, simple and highly sensitive method for spectrofluorimetric determination of amiloride (AMI) and furosemide (FUR) in pharmaceuticals is presented. The proposed method is based on the separation of AMI from FUR by solid-phase extraction using a nylon membrane, followed by spectrofluorimetric determination of both drugs, on the solid surface and the filtered aqueous solution, respectively. AMI shows low native fluorescence, but its separation-preconcentration by immobilization (solid-phase extraction) on nylon membrane surface provides a considerable enhancement in fluorescence intensity. The fluorescence determination is carried out at λ_ex = 237, λ_em = 415 nm for FUR; and λ_ex = 365, λ_em = 406 nm for AMI. The calibration graphs are linear in the range 3.20 × 10⁻⁴ to 0.8 μg mL⁻¹and 1.33 × 10⁻³ to 4.0 μg mL⁻¹, for AMI and FUR, respectively, with a detection limit of 9.62 × 10⁻⁵ and 4.01 × 10⁻⁴ μg mL⁻¹ (S/N = 3). The commonly found excipients in commercial pharmaceutical formulations do not interfere. The developed method is successfully applied to the determination of both drugs in pharmaceutical formulations.     

Fluorescence and terbium-sensitised luminescence determination of garenoxacin in human urine and serum

Fluorescence and terbium-sensitised luminescence properties of new quinolone garenoxacin have been studied. The fluorimetric method allows the determination of 0.060-0.600 μg ml⁻¹ of garenoxacin in aqueous solution containing HCl/KCl buffer (pH 1.5) with λ_exc=282 nm and λ_em=421 nm. Micellar-enhanced fluorescence was also studied, leading to a higher than 400% increase in analytical signal in presence of 12 mM sodium dodecyl sulphate (SDS), allowing the determination of 0.020-0.750 μg ml⁻¹ of garenoxacin. The terbium-sensitised luminescence method allows the determination of 0.100-1.500 μg ml⁻¹ of garenoxacin in 12 mM SDS solution containing 0.08 M acetic acid/sodium acetate buffer (pH 4.1) and 7.5 mM Na₂SO₃ (chemical deoxygenation agent), with λ_exc=281 nm and λ_em=546 nm. Relative standard deviation (R.S.D.) values for the three methods were in the range 1.0-2.0%. The proposed procedures have been applied to the determination of garenoxacin in spiked human urine and serum.     

Flow-injection turbidimetric determination of homatropine methylbromide in pharmaceutical formulations using silicotungstic acid as precipitant reagent

A flow-injection turbidimetric procedure exploiting merging zones is proposed for determining homatropine methylbromide (HMB) in pharmaceutical preparations. The determination is based on the precipitation reaction of homatropine methylbromide with silicotungstic acid in acidic medium to form a precipitate, which was measured at 410 nm. The analytical curve was linear in the HMB concentration range from 8.1 × 10⁻⁵ to 2.2 × 10⁻⁴ mol l⁻¹, with a detection limit of 5.0 × 10⁻⁶ mol l⁻¹. The recoveries ranged from 96 to 103%, the sampling frequency was 70 determinations per hour and relative standard deviations were less than 1.5% (n = 10). The results obtained for commercial formulations using the FIA procedure were in good agreement with those obtained by using a comparative method.     

Post-column terbium complexation and sensitized fluorescence detection for the determination of norepinephrine, epinephrine and dopamine using high-performance liquid chromatography

Terbium sensitized fluorescence was used as a post-column detection system to develop a simple, sensitive and rapid high-performance liquid chromatographic method for the simultaneous determination of catecholamines norepinephrine (NE), epinephrine (E) and dopamine (DA).Catecholamines were separated by an ion-pair reversed-phase chromatography on a BDS-Hypersil analytical column with a mobile phase of methanol and 50 mmol l⁻¹ acetate buffer (pH 4.7) containing 1.1 mmol l⁻¹ SOS and 0.11 mmol l⁻¹ EDTA (15+85 v/v).Catecholamines and the internal standard (3,4-dihydroxybenzylamine, DHBA) were post-column derivatized by the addition to the eluent of an alkaline solution containing a stoichiometric mixture of terbium(III) chloride and EDTA. Fluorescence detection (λ_ex=300 nm, λ_em=545 nm) is based on the sensitization of terbium ion fluorescence after complexation with catecholamines.The chemical compatibility between the eluent and the post-column reagent was studied and the analytical characteristics of the method were established. Detection limits found were 1.0×10⁻⁸, 4.0×10⁻⁸ and 7.0×10⁻⁸ mol l⁻¹ for NE, E and DA, respectively. The method has been successfully applied to the determination of catecholamines in urine samples after solid-phase extraction (SPE) pre-treatment. Recoveries from urine spiked with NE (4.0×10⁻⁷, 2.0×10⁻⁶ and 4.0×10⁻⁶ mol l⁻¹), E (8.2×10⁻⁸, 4.1×10⁻⁷ and 8.2×10⁻⁷ mol l⁻¹) and DA (1.0×10⁻⁶, 5.0×10⁻⁶ and 1.0×10⁻⁵ mol l⁻¹) varied from 98 to 100% (mean=99.3%), from 106 to 107% (mean=106.3%) and from 98 to 101% (mean=99.3%), respectively. The between-run precision (relative standard deviation, R.S.D.) for the method for three urine samples at different concentration levels of each catecholamine varied from 3.6 to 7.0%.     

Flow-injection determination of hydrogen peroxide based on fluorescence quenching of chromotropic acid catalyzed with Fe(II)

Flow-injection analysis system (FIA system), which was based on Fe(II)-catalyzed oxidation of chromotropic acid with hydrogen peroxide, was developed for the determination of hydrogen peroxide. The chromotropic acid has a fluorescence measured at λ_em = 440 nm (emission wavelength) with λ_ex = 235 nm (excitation wavelength), and the fluorescence intensity at λ_em = 440 nm quietly decreased in the presence of hydrogen peroxide and Fe(II), which was caused by Fe(II)-catalyzed oxidation of chromotropic acid with hydrogen peroxide. By measuring the difference of fluorescence intensity, hydrogen peroxide (1.0 × 10⁻⁸-1.0 × 10⁻³ mol L⁻¹) could be determined by the proposed FIA system, whose analytical throughput was 40 samples h⁻¹. The relative standard deviation (RSD) was 1.03% (n = 10) for 4.0 × 10⁻⁸ mol L⁻¹ hydrogen peroxide. The proposed FIA technique could be applied to the determination of hydrogen peroxide in rain water samples.     

Voltammetric determination of L-dopa using an electrode modified with trinuclear ruthenium ammine complex (Ru-red) supported on Y-type zeolite

The L-dopa is the immediate precursor of the neurotransmitter dopamine. Unlike dopamine, L-dopa easily enters the central nervous system and is used in the treatment of Parkinson’s disease. A sensitive and selective method is presented for the voltammetric determination of L-dopa in pharmaceutical formulations using a carbon paste electrode modified with trinuclear ruthenium ammine complex [(NH₃)₅Ru^IIIORu^IV(NH₃)₄ORu^III(NH₃)₅]⁶⁺ (Ru-red) incorporated in NaY zeolite. The parameters which influence on the electrode response (paste composition, potential scan rate, pH and interference) were also investigated. The optimum conditions were found to an electrode composition (m/m) of 25% zeolite containing 6.7% Ru, 50% graphite and 25% mineral oil in acetate buffer at pH 4.8. Voltammetric peak currents showed a linear response for L-dopa concentration in the range between 1.2×10⁻⁴ and 1.0×10⁻² mol l⁻¹ (r=0.9988) with a detection limit of 8.5×10⁻⁵ mol l⁻¹. The variation coefficient for a 1.0×10⁻³ mol l⁻¹ L-dopa (n=10) was 5.5%. The results obtained for L-dopa in pharmaceutical formulations (tablet) was in agreement with compared official method. In conclusion, this study has illustrated that the proposed electrode modified with Ru-red incorporated zeolite is suitable valuable for selective measurements of L-dopa.     

Flow-injection chemiluminescence determination of fluoroquinolones by enhancement of weak chemiluminescence from peroxynitrous acid

A flow-injection chemiluminescence (CL) method is described for the determination of fluoroquinolones including ciprofloxacin, norfloxacin and ofloxacin. The method is based on the enhancement by these compounds of the weak CL from peroxynitrous acid. The linear ranges are 1.0×10⁻⁷ to 1.0×10⁻⁵ mol l⁻¹ for ciprofloxacin and norfloxacin, and 3.0×10⁻⁷ to 3.0×10⁻⁵ mol l⁻¹ for ofloxacin, respectively. The detection limits (S/N=3) are 4.5×10⁻⁸ mol l⁻¹ ciprofloxacin, 5.9×10⁻⁸ mol l⁻¹ norfloxacin and 1.1×10⁻⁷ mol l⁻¹ ofloxacin, respectively. The proposed method was applied to the determination of fluoroquinolones in pharmaceutical preparations.     

Analysis of salicylic acid based on the fluorescence enhancement of the As(III)-salicylic acid system

A new, simple and sensitive spectrofluorimetric method for the determination of salicylic acid (λ_ex = 315 nm, λ_em = 408 nm) using As(III) as a sensitizing reagent has been investigated by measuring the increase of fluorescence intensity of salicylic acid due to the complexation of As(III)-salicylic acid in presence of sodium dodecyl sulfate (SDS) 10⁻³ M. Under optimum conditions, a significant relationship was obtained between the fluorescence intensity and salicylic acid concentration. A linear calibration curve was obtained in the range 13.8-13812 μg l⁻¹ with product-moment correlation coefficient (R) 0.99985 and detection limit 4.2 μg l⁻¹. The R.S.D. is 2.35% (n = 5).The method was applied successfully to the determination of salicylic acid in human serum.     

Ultrasensitive determination of silver ion based on synchronous fluorescence spectroscopy with nanoparticles

Based on the characteristics of synchronous fluorescence spectroscopy (SFS), a new method with high sensitivity and selectivity was developed for rapid determination of silver ion with functional cadmium sulphide (CdS) nanoparticles as a fluorescence probe. When Δλ (λ_em − λ_ex) = 215 nm, maximum synchronous fluorescence is produced at 304 nm. Under optimal conditions, functional cadmium sulphide displayed a calibration response for silver ion over a wide concentration range from 0.8 × 10⁻¹⁰ to 1.5 × 10⁻⁸ mol L⁻¹. The limit of detection was 0.4 × 10⁻¹⁰ mol L⁻¹ and the relative standard deviation of seven replicate measurements for the lowest concentration (0.8 × 10⁻¹⁰ mol L⁻¹) was 2.8%. Compared with several fluorescence methods, the proposed method had a wider linear range and improved the sensitivity. Furthermore, the concentration dependence of the synchronous fluorescence intensity is effectively described by a Langmuir-type binding isotherm.     

Automatic miniaturized fluorometric flow system for chemical and toxicological control of glibenclamide

In this work, and for the first time, it was developed an automatic and fast screening miniaturized flow system for the toxicological control of glibenclamide in beverages, with application in forensic laboratory investigations, and also, for the chemical control of commercially available pharmaceutical formulations. The automatic system exploited the multipumping flow (MPFS) concept and allowed the implementation of a new glibenclamide determination method based on the fluorometric monitoring of the drug in acidic medium (λ_ex = 301 nm; λ_em = 404 nm), in the presence of an anionic surfactant (SDS), promoting an organized micellar medium to enhance the fluorometric measurements.The developed approach assured good recoveries in the analysis of five spiked alcoholic beverages. Additionally, a good agreement was verified when comparing the results obtained in the determination of glibenclamide in five commercial pharmaceutical formulations by the proposed method and by the pharmacopoeia reference procedure.     

A multicommuted flow system for sequential spectrophotometric determination of hydrosoluble vitamins in pharmaceutical preparations

A multicommuted flow system is proposed for spectrophotometric determination of hydrosoluble vitamins (ascorbic acid, thiamine, riboflavine and pyridoxine) in pharmaceutical preparations. The flow manifold was designed with computer-controlled three-way solenoid valves for independent handling of sample and reagent solutions and a multi-channel spectrophotometer was employed for signal measurements. Periodic re-calibration as well as the standard addition method was implemented by using a single reference solution. Linear responses (r=0.999) were obtained for 0.500-10.0 mg l⁻¹ ascorbic acid, 2.00-50.0 mg l⁻¹ thiamine, 5.00-50.0 mg l⁻¹ riboflavine and 0.500-8.00 mg l⁻¹ pyridoxine. Detection limits were estimated as 0.08 mg l⁻¹ (0.5 μmol l⁻¹) ascorbic acid, 0.8 mg l⁻¹ (2 μmol l⁻¹) thiamine, 0.2 mg l⁻¹ (0.5 μmol l⁻¹) riboflavine and 0.1 mg l⁻¹ (0.9 μmol l⁻¹) pyridoxine at 99.7% confidence level. A mean sampling rate of 60 determinations per hour was achieved and coefficients of variation of 1% (n=20) were estimated for all species. The mean reagent consumption was 25-fold lower in relation to flow-based procedures with continuous reagent addition. Average recoveries between 95.6 and 100% were obtained for commercial pharmaceutical preparations. Results agreed with those obtained by reference methods at 95% confidence level. The flow system is suitable for application in quality control processes and in dissolution studies of vitamin tablets.     

A novel spectrofluorimetric method for the ultra trace analysis of nitrite and nitrate in aqueous medium and its application to air, water, soil and forensic samples

A highly sensitive and virtually specific method has been developed for the trace and ultra trace 5 ng ml⁻¹-1 μg ml⁻¹ fluorimetric analysis of nitrite. The method is based on the quenching action of nitrite on the native fluorescence of murexide (ammonium purpurate) [λ_ex=349.0 nm, λ_em=444.5 nm] in the acid range of 0.045-0.315 (M) H₂SO₄. The method is very precise and accurate (S.D.=±0.4877 and R.S.D.=0.4878% for the determination of 0.1 μg ml⁻¹ of nitrite in 11 replicates). Relatively large excesses of over 35 cations and anions do not interfere. The proposed technique has been successfully applied for the determination of nitrite and nitrate in ground water, surface water and sea water, nitrite in soil and nitrate in forensic samples. The method has also been extended for the analysis of NO_x in air.     

Development of a novel flow injection liquid-liquid microextraction method for the on-line separation and preconcentration for determination of zinc(II) using 5-(8-hydroxy-2-quinolinylmethyl)-2,8-dithia-5-aza-2,6-pyridinophane as a sensitive and selective fluorescent chemosensor

A novel flow injection analysis (FIA) system based on liquid-liquid microextraction and fluorimetric determination was developed for the determination of traces of the Zn²⁺ ion using 5-(8-hydroxy-2-quinolinylmethyl)-2,8-dithia-5-aza-2,6-pyridinophane (L) as a sensitive and selective fluorimetric sensor, with λ_ex = 373 nm and λ_em = 530 nm, and hexanol as the extracting organic solvent. In the designed FIA system, the phase separation takes place via gravitation forces in the absence of any segmenter. The influence of pH and ionic strength of the solution, amount of ligand, nature of counter ion, volume of organic solvent, extraction time and coil length was investigated. Under optimized experimental conditions, the calibration curve found to be liner over a concentration range of 0.025-4.53 μg mL⁻¹ (R² = 0.9951) with a limit of detection of 2.3 ng mL⁻¹. The enrichment factor was 45 and relative standard deviation for 7 replicate determinations was 2.43%. The method is very fast and uses low levels of organic solvents. The proposed method was applied successfully to the determination of zinc(II) in human hair, human serum and two inorganic sludge samples.     

Synergistic flotation of U(VI)-alizarin complex with some diamines followed by spectrophotometric determination of U(VI) using 4,4′-diaminophenylmethane

In this work, synergistic flotation of U(VI)-alizarin complex at the presence of some diamine compounds was firstly investigated by the spectrophotometric method. The flotation process was carried out on aliquots of 100 ml of U(VI) solutions containing alizarin and the diamine at pH of 5.00 using n-heptane. The floated layer was then dissolved in acetonitrile and its absorbance was measured. Since the synergistic effect of 4,4′-diaminophenylmethane (dapm) was much more than the others, it was used for the determination of U(VI) by this method. Beer's law was obeyed (λ_max = 591 nm) in the range of 5 × 10⁻⁷ to 1 × 10⁻⁵ mol l⁻¹ with the apparent molar absorptivity of 1.12 × 10⁶ l mol⁻¹ cm⁻¹, and a correlation coefficient of 0.9991. The detection limit (n = 7) was 1 × 10⁻⁷ mol l⁻¹, and the R.S.D. (n = 7) obtained for 4 × 10⁻⁶ mol l⁻¹ of U(VI) was 2.23%. Except that only a few analogous cations, which could be masked by EDTA, no interference was observed at the presence of various conventional ions, even at high concentrations. The reliability and applicability of the method were confirmed using some geological standard reference materials and spiked synthetic water samples, respectively.     

Determination of benorilate in pharmaceutical formulations and its metabolite in urine at carbon paste electrode modified by silver nanoparticles

Benorilate was determined by the differential pulse voltammetry (DPV) using a carbon paste electrode modified by silver nanoparticles in 1.25 × 10⁻³ mol l⁻¹ KH₂PO₄ and Na₂HPO₄ buffer solution (pH = 6.88, 25 °C) .The anodic peak potential was +0.970 V (versus SCE). A good linear relationship was realized between the anodic peak currents and benorilate concentrations in the range of 1.0 × 10⁻⁷ to 2.5 × 10⁻⁴ mol l⁻¹ with the detection limit of 1.0 × 10⁻⁸ mol l⁻¹. The recovery was 95.2-103.6% with the relative standard deviation of 3.6% (n = 9). The pharmaceutical preparations, benorilate tablets samples and its metabolite (salicylic acid) in urine were determined with the desirable results.